Immunodiagnostic Systems Holdings Plc (IDH.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 514 | 1,774 | -1,524 | 3,763 | -855 |
| Other Working Capital | -1,355 | -1,709 | 3,618 | 4,312 | -1,930 |
| Other Operating Activity | 10,309 | 12,224 | 16,262 | 5,693 | 19,179 |
| Operating Cash Flow | $9,468 | $12,289 | $18,356 | $13,768 | $16,394 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,643 | -2,308 | -2,652 | -4,346 | -8,181 |
| Net Acquisitions | -2,540 | 0 | -105 | N/A | -1,907 |
| Purchase Sale Intangibles | -3,587 | -3,748 | -2,256 | -2,485 | N/A |
| Other Investing Activity | 158 | 141 | 24 | 241 | 218 |
| Investing Cash Flow | $-8,612 | $-5,915 | $-4,989 | $-6,590 | $-9,870 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | -4,152 | N/A | N/A |
| Debt Repayment | -116 | N/A | N/A | -2,027 | -4,895 |
| Common Stock Issued | 49 | 1,784 | 0 | 696 | 74 |
| Dividend Paid | -2,479 | -866 | -779 | -708 | -559 |
| Other Financing Activity | -58 | -64 | -10 | -25 | -56 |
| Financing Cash Flow | $-2,604 | $854 | $-4,941 | $-2,064 | $-5,436 |
| Exchange Rate Effect | -1,212 | -103 | 108 | N/A | N/A |
| Beginning Cash Position | 26,690 | 19,565 | 11,031 | 6,364 | 5,276 |
| End Cash Position | 23,730 | 26,690 | 19,565 | 11,031 | 6,364 |
| Net Cash Flow | $-1,748 | $7,228 | $8,426 | $4,667 | $1,088 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,468 | 12,289 | 18,356 | 13,768 | 16,394 |
| Capital Expenditure | -6,459 | -6,056 | -4,908 | -6,831 | -8,181 |
| Free Cash Flow | 3,009 | 6,233 | 13,448 | 6,937 | 8,213 |